share_log

Truist Securities Maintains Buy on Edgewise Therapeutics, Maintains $25 Price Target

Moomoo 24/7 ·  Apr 17 13:19

Truist Securities analyst Srikripa Devarakonda maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Buy and maintains $25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment